Staphylococcus

Experimental Therapeutics
Combinations of Vancomycin and β-Lactams Are Synergistic against Staphylococci with Reduced Susceptibilities to Vancomycin
Michael W. Climo, Roberto L. Patron, Gordon L. Archer
Mechanisms of Resistance
Distribution of Genes Encoding Resistance to Macrolides, Lincosamides, and Streptogramins among Staphylococci
Gerard Lina, Alain Quaglia, Marie-Elisabeth Reverdy, Roland Leclercq, François Vandenesch, Jerome Etienne
Mechanisms of Resistance
Characterization of a Staphylococcal Plasmid Related to pUB110 and Carrying Two Novel Genes, vatC andvgbB, Encoding Resistance to Streptogramins A and B and Similar Antibiotics
Jeanine Allignet, Nadia Liassine, Névine El Solh
Experimental Therapeutics
Efficacy of Trovafloxacin, a New Quinolone Antibiotic, in Experimental Staphylococcal Endocarditis Due to Oxacillin-Resistant Strains
Arnold S. Bayer, Cong Li, Michael Ing
Susceptibility
Effects of Slime Produced by Clinical Isolates of Coagulase-Negative Staphylococci on Activities of Various Antimicrobial Agents
Maria Souli, Helen Giamarellou
Mechanisms of Resistance
Determination of the Chromosomal Relationship between mecA and gyrA in Methicillin-Resistant Coagulase-Negative Staphylococci
Paul D. Fey, Michael W. Climo, Gordon L. Archer
Mechanisms of Resistance
Decreased Susceptibilities to Teicoplanin and Vancomycin among Coagulase-Negative Methicillin-Resistant Clinical Isolates of Staphylococci
Krzysztof Sieradzki, Paolo Villari, Alexander Tomasz

Pages